Study: Drug, chemo combo double survival in metastatic lung cancer

Combining the immunotherapy drug pembrolizumab with chemotherapy doubles survival in patients with some forms of lung cancer compared with chemo alone.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news